Replies to post #3415 on CNBX Pharmaceuticals Inc (CNBX)

[LongShot_Louie]

What I find egregious is they indicate....

they are not pricing this based on anything related to cost (be it research costs, production costs and/or marketing costs). The article suggests the cost is based on what other companies are currently charging for drugs designed to affect the same illness. In other words, they want $32,500 per year because that's what the market will currently bear. JMHO